Your browser doesn't support javascript.
loading
Assessment of the Anti-Breast Cancer Effects of Urolithin with Molecular Docking Studies in the In Vitro Condition: Introducing a Novel Chemotherapeutic Drug.
Han, Lu; Zhao, Danbo; Li, Ya; Jin, Jianwei; El-Kott, Attalla F; Al-Saeed, Fatimah A; Eldib, Ali M.
Afiliação
  • Han L; Department of General Surgery, Sijing Hospital of Songjiang District Shanghai, Shanghai, 201601, China.
  • Zhao D; Department of Oncology, Ezhou Central Hospital, Ezhou, 436000, Hubei, China.
  • Li Y; Shaanxi Provincial Cancer Hospital, Xi'an, Shaanxi, 710061, China.
  • Jin J; Department of Oncology, The Third Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, 310000, Zhejiang, China. star3531@sina.com.
  • El-Kott AF; Department of Biology, College of Science, King Khalid University, Abha, 61421, Kingdom of Saudi Arabia.
  • Al-Saeed FA; Department of Zoology, College of Science, Damanhour University, Damanhour, 22511, Egypt.
  • Eldib AM; Department of Biology, College of Science, King Khalid University, Abha, 61421, Kingdom of Saudi Arabia.
Mol Biotechnol ; 66(3): 554-566, 2024 Mar.
Article em En | MEDLINE | ID: mdl-37280483

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Aldeído Redutase Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Aldeído Redutase Idioma: En Ano de publicação: 2024 Tipo de documento: Article